Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Published on by Top Teachers

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Published on by Top Teachers

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Published on by Top Teachers

Dr. Hui Saan Tham | Medicine and Health Sciences | Research Excellence Award

Han Neuro Acupuncture & Herbal Specialist | Malaysia

Dr. Hui Saan Tham is a distinguished practitioner and academic in Chinese Medicine, specializing in acupuncture for complex neurological and spinal disorders. She holds a PhD in Acupuncture from Guangzhou University of Chinese Medicine and serves as Founder and Director of HAN Neuro Acupuncture & Herbal Specialist in Malaysia, a globally recognized center attracting patients from over 50 countries. Dr. Tham pioneered the Micro Perception In-Depth (MPID) and Palpation Guided Acupuncture (PGA) systems, advancing diagnostic precision and clinical outcomes. With multiple peer-reviewed publications and international conference presentations, she actively contributes to research and education. She has held key advisory roles at International Medical University and international committees, promoting curriculum development and professional standards. Her work significantly impacts global healthcare by integrating traditional knowledge with modern clinical and technological innovations.

Google Scholar

Featured Publications

WD Wang, SY Mok, YM Lim, HS Tham, LF Tan, CN Foo, CPY Lim (2026).
Development and Preliminary Evaluation of an EfficientNet-Based Deep Learning System for Ultrasound Assessment of Neck Disorders: A Single-Center Study
Diagnostics | Journal Article · 2026

(2017).
Palpation Methods and Influencing Factors in Acupuncture
Journal of Shandong University of Traditional Chinese Medicine | Journal Article · 2017

Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Published on by Top Teachers

Dr. Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Hamamatsu University School of Medicine | Bangladesh

Dr. Mohammad Khaja Mafij Uddin is an Associate Scientist in the Infectious Diseases Division at icddr,b, with over 15 years of expertise in mycobacteriology and tuberculosis (TB) diagnostics. His work integrates molecular, microbiological, and immunological approaches to advance TB detection, drug resistance analysis, and biomarker discovery. He has led and contributed to multiple internationally funded projects, including collaborations with organizations in France, Korea, and the USA, focusing on innovative diagnostics such as targeted next-generation sequencing and non-respiratory TB detection. Dr. Uddin has authored several peer-reviewed publications in high-impact journals, contributing significantly to understanding TB transmission dynamics and extrapulmonary TB. He has mentored graduate students and strengthened laboratory capacity, with his research directly supporting improved TB diagnosis and public health outcomes in high-burden settings.

Citation Metrics (Scopus)

94
75
50
25
0

Citations
94

h-index
4

Documents
5

Citations

h-index

Documents

Featured Publications

Joan-Lluis Vives Corrons | Health Sciences | Outstanding Scientist Award

Published on by Top Teachers

Prof. Joan-Lluis Vives Corrons | Health Sciences | Outstanding Scientist Award

Academic Background

Prof. Joan-Lluis Vives-Corrons holds a Medical Doctor degree and is a specialist in Haematology from the University of Barcelona. He completed advanced training as a fellow at Hôpital Beaujon in Paris and as a visiting fellow at The Scripps Research Institute. He has served as a professor of Medicine at the University of Barcelona and has been deeply involved in education and mentorship in haematology throughout his career. According to Scopus and Google Scholar records, his work has been cited extensively, with over 1,467 documents citing his research, 81 documents authored, and an h-index of 21, reflecting his sustained influence in the field.

Research Focus

Prof. Joan-Lluis Vives Corrons research focuses on the study of rare and congenital anaemias, encompassing the molecular and genetic mechanisms underlying red blood cell disorders. He has a strong interest in the standardization of haematology laboratory practices and in improving diagnostic approaches for haemoglobinopathies and enzymopathies. His work bridges clinical practice and translational research to advance patient care for rare anaemias.

Work Experience

Prof. Joan-Lluis Vives Corrons has held leadership roles in haematology laboratories and clinical departments, serving as head of the Haematology Laboratory and Red Cell Pathology Units at the Hospital Clinic of the University of Barcelona. He has also led the Red Cell Pathology and Haematopoietic Disorders Research Group at the Josep Carreras Institute for Leukemia Research and currently oversees the Clinical Centre for Ambulatory Medicine in Barcelona. He has coordinated large-scale networks for the diagnosis and follow-up of rare haematological disorders, contributing significantly to public health programs such as newborn screening for sickle-cell disease.

Key Contributions

Prof. Joan-Lluis Vives Corrons has pioneered the development of diagnostic methods for rare anaemias, implemented quality assessment schemes in haematology, and contributed to the standardization of automated laboratory analyzers. His research has led to the discovery of multiple novel mutations in genes responsible for red blood cell disorders, enhancing the understanding of their molecular basis. He has facilitated international collaboration through European networks for rare anaemias and supported education and training programs for haematologists and laboratory professionals.

Awards & Recognition

Recognized for his exceptional research and leadership, Prof. Vives-Corrons has been honored with the Outstanding Scientist Award for his groundbreaking contributions to the study of rare anaemias. His work is widely acknowledged for advancing clinical and laboratory haematology practice while fostering global collaborations in rare disease research.

Professional Roles & Memberships

Prof. Joan-Lluis Vives Corrons has held significant professional roles, including Secretary General of the International Society of Haematology and representative membership in the European Union Committee of Experts in Rare Diseases. He is affiliated with multiple national and international scientific societies and serves on editorial boards of leading journals in haematology. His work with ORPHANET, EURORDIS, and various standardization organizations underscores his commitment to improving rare disease diagnostics and care.

Profile

Scopus | Orcid 

Featured Publications

Vives-Corrons, J. L., et al. (2024). SARS-CoV-2 infection and anemia—A focus on RBC deformability and membrane proteomics—Integrated observational prospective study. Microorganisms.

Vives-Corrons, J. L., et al. (2023). The pyruvate kinase deficiency global longitudinal (Peak) registry: Rationale and study design. BMJ Open.

Vives-Corrons, J. L., et al. (2022). Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content. Blood Cells, Molecules and Diseases.

Vives-Corrons, J. L., et al. (2022). Concomitant hereditary spherocytosis and pyruvate kinase deficiency in a Spanish family with chronic hemolytic anemia: Contribution of laser ektacytometry to clinical diagnosis. Cells.

Vives-Corrons, J. L., et al. (2022). Red cell ektacytometry in two patients with chronic hemolytic anemia and three new α-spectrin variants. Annals of Hematology.

Impact Statement / Vision

Prof. Joan-Lluis Vives Corrons to advance the understanding and management of rare anaemias through innovative research, international collaboration, and the integration of molecular diagnostics into clinical practice. His vision emphasizes improving patient outcomes while promoting education and quality standards in haematology worldwide.

 

Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

Published on by Top Teachers

Ernest Moore | Medicine | Best Researcher Award

Published on by Top Teachers

Dr. Ernest Moore | Medicine | Best Researcher Award

Director of Research at Ernest E Moore Shock Trauma Center at Denver Health,United States.

Dr. Ernest E. Moore is a globally renowned trauma surgeon and researcher with an illustrious career spanning decades. He has made groundbreaking contributions to trauma surgery, critical care, and acute care surgery. As a Distinguished Professor of Surgery at the University of Colorado Denver and Director of Surgical Research at the Ernest E. Moore Shock Trauma Center, he has led pioneering research initiatives. His expertise in trauma-induced coagulopathy and injury control has shaped modern surgical protocols. Dr. Moore has mentored numerous medical professionals and served as Editor of the Journal of Trauma and Acute Care Surgery. His contributions to trauma research have been widely recognized with numerous awards and honorary fellowships. His work has significantly improved emergency medicine, trauma care, and patient survival rates globally. With extensive publications, federal research grants, and leadership in prestigious institutions, Dr. Moore remains a key figure in trauma surgery and critical care advancements.

professional profiles📖

Scopus Profile

Education 🎓

Dr. Ernest E. Moore pursued his medical education at a prestigious institution, establishing a strong foundation in surgery and trauma care. He completed his medical degree (MD) with top distinctions, excelling in surgical sciences and emergency medicine. Following his degree, he undertook rigorous residency training in general surgery, gaining extensive hands-on experience in trauma care and acute surgery. Furthering his expertise, he completed a fellowship in trauma and critical care surgery, specializing in life-saving interventions and emergency procedures. His dedication to academic excellence led him to advanced research training, focusing on trauma-induced coagulopathy and surgical innovations. Over the years, he has contributed to medical education through teaching, mentorship, and groundbreaking research. His academic achievements have been instrumental in shaping modern trauma care protocols. Dr. Moore’s continuous commitment to education and research has made him a leader in the field of trauma surgery and critical care.

work Experience💼

Dr. Ernest E. Moore has held numerous prestigious positions throughout his career, significantly impacting trauma surgery and emergency medicine. He has served as a Distinguished Professor of Surgery at the University of Colorado Denver, where he has mentored future surgeons and led innovative research initiatives. As the Director of Surgical Research at the Ernest E. Moore Shock Trauma Center, he has spearheaded groundbreaking studies on trauma care. Dr. Moore has also been a principal investigator for multiple Department of Defense (DOD) and National Institutes of Health (NIH) projects, focusing on acute coagulopathy, trauma response, and injury control. He played a pivotal role as the Editor of the Journal of Trauma and Acute Care Surgery (2012–2022), influencing trauma research worldwide. His extensive clinical and academic experience has led to advancements in emergency medicine, surgical protocols, and patient survival outcomes, making him a global leader in trauma care.

Skills 🛠️

Dr. Ernest E. Moore possesses a diverse and highly specialized skill set that has propelled him to the forefront of trauma surgery and critical care. His expertise in trauma surgery and emergency medicine has led to life-saving interventions for critically injured patients. As a renowned researcher, he has spearheaded groundbreaking studies on trauma-induced coagulopathy, hemorrhagic shock, and clot structure, shaping modern surgical protocols. His leadership and mentorship skills are evident through his role as a Distinguished Professor and Director of Surgical Research, where he has guided countless medical professionals. Dr. Moore’s medical writing and editing experience, including a decade-long tenure as Editor of the Journal of Trauma and Acute Care Surgery, reflects his ability to influence global trauma research. He excels in interdisciplinary collaboration, securing DOD and NIH research grants while integrating advancements in bioengineering and emergency response. His dedication to patient care, surgical education, and innovation continues to revolutionize trauma medicine.

Research Focus

Dr. Ernest E. Moore’s research primarily focuses on trauma surgery, critical care, and acute injury response. His groundbreaking work on trauma-induced coagulopathy has led to improved treatment protocols for severely injured patients. He has extensively studied clot structure following polytrauma, aiming to enhance coagulation therapies. His research also delves into pulmonary embolism post-injury, developing strategies for early detection and prevention. As a principal investigator on multiple DOD and NIH-funded projects, he has pioneered research on trauma prime cells and combat casualty care. His studies on hemorrhagic shock have influenced modern resuscitation techniques, leading to better patient survival rates. Dr. Moore’s interdisciplinary approach integrates surgical innovation, emergency response, and translational medicine. His contributions to trauma care continue to revolutionize treatment methods, making a lasting impact on the field of emergency and critical care surgery..

Awards & Honors🏆 

Dr. Ernest E. Moore has received numerous prestigious awards and honors in recognition of his contributions to trauma surgery and medical research. He has been awarded multiple honorary fellowships from esteemed surgical and medical organizations worldwide. His leadership in trauma care has earned him accolades from the Department of Defense (DOD) and National Institutes of Health (NIH) for his research excellence. He has also received lifetime achievement awards from leading trauma and surgical associations. As a testament to his global impact, he has been invited as a keynote speaker at international medical conferences and has been recognized for his pioneering work in trauma-induced coagulopathy and critical care. His contributions as an editor, researcher, and mentor have been celebrated through numerous academic honors, solidifying his reputation as a trailblazer in the field of trauma surgery.

Conclusion✅

Dr. Ernest E. Moore’s outstanding research career, leadership in trauma surgery, and groundbreaking contributions to emergency medicine make him a highly suitable candidate for the Best Researcher Award. His extensive portfolio of funded research, global recognition, and clinical impact solidify his position as a top contender. Minor enhancements in interdisciplinary research and public science engagement could further elevate his profile.

Publications to Noted 📚

Title: COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study

Authors: B. de Simone, Belinda; F.M. Abu-Zidan, Fikri M.; L. Kasongo, Lucienne; R.P. Knut, Ruslan P.; R.I. Sydorchuk, R. Igorovich

Citations: 0

Year: Not specified

Title: Indocyanine green fluorescence-guided surgery in the emergency setting: the WSES international consensus position paper

Authors: B. de Simone, Belinda; F.M. Abu-Zidan, Fikri M.; L. Boni, Luigi; C.A. Schena, Carlo Alberto; F. Catena, Fausto

Citations: 0

Year: 2025

Title: Correction to: Surgical stabilization of rib fractures (SSRF): the WSES and CWIS position paper

Authors: G. Sermonesi, Giacomo; R. Bertelli, Riccardo; F.M. Pieracci, Fredric Michael; E.E. Moore, Eugene E.; F. Catena, Fausto

Citations: 0

Year: 2024